OCUL | Ocular TherapeutixNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$6.82
+$0.09 (+1.34%)

Ocular Therapeutix (OCUL) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $6.82 vs 50 $8.65 / 200 $9.07
Projection
No cross projected
Test
Cross test window open, no test bar yet
Last cross
Death cross 23 Oct 2026 ยท projected 16 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $6.97 vs 50 $9.60 / 200 $7.80
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 11 Nov 2024 ยท projected 27 bars out ยท tested 3 bars

4-hour as of 3 Nov 13:30 ET

Price
below both $6.86 vs 50 $7.07 / 200 $9.11
Projection
No cross projected
Test
No active test
Last cross
Death cross 8 Oct 2026 ยท projected 20 bars out

Cross history

34
crosses on record since 2017
17 golden17 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
23 Oct 2026Death moderatedaily16 bars outActive Cross Test
8 Oct 2026Death4-hour20 bars outNot tested
22 Sep 2026Golden flatdaily27 bars out2 bar cross test
18 Aug 2026Golden4-hour11 bars outNot tested
14 Aug 2026Death4-hour24 bars outNot tested

About OCUL

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$21.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.